Dolby Laboratories (DLB) Tops Q2 EPS by 7c ; Offers Guidance

Dolby Laboratories (NYSE: DLB) reported Q2 EPS of $1.34, $0.07 better than the analyst estimate of $1.27. Revenue for the quarter came in at $370 million versus the consensus estimate of $376.38 million.

GUIDANCE:

Dolby Laboratories sees Q3 2025 EPS of $0.62-$0.77, versus the consensus of $0.81. Dolby Laboratories sees Q3 2025 revenue of $290-320 million, versus the consensus of $307.1 million.

Dolby Laboratories sees FY2025 EPS of $3.88-$4.03, versus the consensus of $4.04. Dolby Laboratories sees FY2025 revenue of $1.31-1.38 billion, versus the consensus of $1.35 billion.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.

You May Also Be Interested In

• Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
• Goldcana closes $1M private placement of flow-through shares
• Therma Bright plans $420,000 non-brokered private placement